Suppr超能文献

XIAP和p63在腺瘤样增生、非典型腺瘤样增生、细支气管肺泡癌及高分化腺癌中的免疫组化检测

Immunohistochemical detection of XIAP and p63 in adenomatous hyperplasia, atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and well-differentiated adenocarcinoma.

作者信息

Wu Maoxin, Orta Lurmag, Gil Joan, Li Gan, Hu Alice, Burstein David E

机构信息

1Department of Pathology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.

出版信息

Mod Pathol. 2008 May;21(5):553-8. doi: 10.1038/modpathol.2008.5. Epub 2008 Feb 1.

Abstract

The critical distinction of bronchioloalveolar carcinoma (BAC), well-differentiated adenocarcinoma (WDAC) of lung, adenomatous hyperplasia (AH) and atypical adenomatous hyperplasia (AAH), is based on morphological criteria alone, and is therefore potentially subjective. We examined expression of two markers, X-linked inhibitor of apoptosis protein (XIAP), the most potent of the inhibitor of apoptosis protein (IAP) family, and p63, a marker of bronchial reserve cells (BRC) and squamous cells, in these entities. H&E slides of 37 tissue blocks from 27 patients were reviewed and classified as AH (n=7), AAH (n=8), BAC (n=9) and WDAC (n=13). Immunostaining was performed on 4 mum sections with monoclonal anti-XIAP and monoclonal anti-p63. Granular or heterogeneous cytoplasmic staining for XIAP and nuclear staining for p63 were considered positive. Neither XIAP nor p63 were detected in normal lung alveolar cells. All seven AHs were negative for XIAP and negative or focally positive for p63. All eight AAHs were positive for XIAP and displayed p63 positivity in scattered cells. All BACs displayed XIAP positivity, which ranged from focal/weak to diffuse/strong. p63 was negative in seven and focally positive in two of nine BACs. Twelve of 13 WDACs showed XIAP positivity in a similar pattern to BAC; all were negative for p63. One aberrant case diagnosed on H & E as WDAC was negative for XIAP but strongly positive for p63. Significant XIAP expression appears to be useful for distinguishing AAH from AH. Commonality of XIAP staining in AAH, BAC and WDAC supports the possibility that AAH may be a pre-malignant lesion. The rarity of p63 expression confirms previous reports and supports a nonbronchial histogenesis of these entities. In contrast, diffuse p63 staining may facilitate the identification of rare cases that may have been misclassified as alveolar in origin based on morphology but may be of BRC origin.

摘要

细支气管肺泡癌(BAC)、肺高分化腺癌(WDAC)、腺瘤样增生(AH)和不典型腺瘤样增生(AAH)的关键区分仅基于形态学标准,因此具有潜在的主观性。我们检测了两种标志物的表达,即X连锁凋亡抑制蛋白(XIAP)(凋亡抑制蛋白(IAP)家族中最有效的一种)和p63(支气管储备细胞(BRC)和鳞状细胞的标志物)在这些病变中的表达情况。回顾了来自27例患者的37个组织块的苏木精-伊红(H&E)切片,并将其分类为AH(n = 7)、AAH(n = 8)、BAC(n = 9)和WDAC(n = 13)。用单克隆抗XIAP和单克隆抗p63对4μm切片进行免疫染色。XIAP的颗粒状或异质性细胞质染色以及p63的核染色被视为阳性。在正常肺泡细胞中未检测到XIAP和p63。所有7例AH对XIAP均为阴性,对p63为阴性或局灶性阳性。所有8例AAH对XIAP均为阳性,且散在细胞中显示p63阳性。所有BAC均显示XIAP阳性,范围从局灶性/弱阳性到弥漫性/强阳性。9例BAC中有7例p63为阴性,2例为局灶性阳性。13例WDAC中有12例显示出与BAC相似模式的XIAP阳性;所有病例p63均为阴性。1例在H&E上诊断为WDAC的异常病例XIAP为阴性,但p63强阳性。显著的XIAP表达似乎有助于区分AAH和AH。AAH、BAC和WDAC中XIAP染色的共性支持了AAH可能是癌前病变的可能性。p63表达罕见证实了先前的报道,并支持这些病变的非支气管组织发生。相比之下,弥漫性p63染色可能有助于识别罕见病例,这些病例可能基于形态学被错误分类为肺泡起源,但可能是BRC起源。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验